Elevance Health Inc. (ELV) vs Regeneron Pharmaceuticals, Inc. (REGN)
A side-by-side comparison of Elevance Health Inc. and Regeneron Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 11, 2026. Differences are shown without an overall score or investment verdict.
ELV
Elevance Health Inc.
$418.72HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
REGN
Regeneron Pharmaceuticals, Inc.
$781.49HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
Total return — ELV vs REGN
growth of $100 · dividends reinvested · last 10yELV +276.6% (+14.2%/yr)REGN +108.5% (+7.6%/yr)ELV compounded faster over this window
ELV REGN
ELV vs REGN: by the numbers
- •ELV is the larger company ($90.81B vs $80.51B market cap).
- •ELV trades at the lower trailing earnings multiple (18.61 vs 19.33 P/E), one valuation lens rather than an overall verdict.
- •REGN converts more revenue to profit (27.86% vs 2.47% net margin).
- •ELV grew revenue faster over the past five years (9.25% vs 4.64% CAGR).
- •ELV pays the higher dividend yield (1.65% vs 0.46%).
Metrics side by side
Valuation
| Metric | ELV | REGN |
|---|---|---|
| P/E ratio | 18.61 | 19.33 |
| Forward P/E | 15.42 | 14.40 |
| P/S ratio | 0.45 | 5.18 |
| P/B ratio | 2.02 | 2.54 |
| EV / EBITDA | 13.82 | 17.79 |
| FCF yield | 6.93% | 4.37% |
Profitability
| Metric | ELV | REGN |
|---|---|---|
| Gross margin | 25.56% | 84.86% |
| Operating margin | 3.51% | 25.56% |
| Net margin | 2.47% | 27.86% |
| ROE | 11.06% | 13.65% |
| ROIC | 6.34% | 9.19% |
Dividends
| Metric | ELV | REGN |
|---|---|---|
| Dividend yield | 1.65% | 0.46% |
| Payout ratio | 30.49% | 9.15% |
Growth (annualized)
| Metric | ELV | REGN |
|---|---|---|
| Revenue CAGR (5Y) | 9.25% | 4.64% |
| EPS CAGR (5Y) | 6.67% | 5.70% |
| FCF CAGR (5Y) | -19.97% | 15.77% |
| Total return CAGR (5Y) | 4.62% | 4.76% |
Frequently asked
- Which has the lower trailing P/E, ELV or REGN?
- ELV has the lower trailing P/E: ELV trades at 18.61 and REGN at 19.33. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ELV or REGN?
- Over the past five years, ELV grew revenue faster — ELV at a 9.25% CAGR versus REGN at 4.64%.
- Does ELV or REGN pay a bigger dividend?
- ELV yields 1.65% and REGN yields 0.46% based on trailing dividends and the latest price.
- Is ELV or REGN more profitable?
- REGN runs the higher net margin — ELV at 2.47% versus REGN at 27.86%.
- How have ELV and REGN total returns compared?
- Over the past 10 years, ELV delivered 14.18% and REGN delivered 7.81% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Elevance Health P/E ratioRegeneron Pharmaceuticals P/E ratioElevance Health dividend yieldRegeneron Pharmaceuticals dividend yieldElevance Health ROERegeneron Pharmaceuticals ROEElevance Health operating marginRegeneron Pharmaceuticals operating marginElevance Health revenue growthRegeneron Pharmaceuticals revenue growthElevance Health free cash flowRegeneron Pharmaceuticals free cash flow
Elevance Health & Regeneron Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 11, 2026.